Clinical °Ë»ö°á°ú

100 °Ç (1/10 ÂÊ)
»ó¼¼Á¶°Ç    ÆÄÀÏÁ¾·ù 

CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW

CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW

¡¥W CONTENTS 1. Clinical Trials 3. Phase 3 2. Phase 1 WHY CLINICAL TRIAL Effectiveness of intervention to treat a disease Safety of a new drug or devic
·¹Æ÷Æ® > ±âŸ   9page   1,000 ¿ø
Clinical Trials

Clinical Trials

Clinical Trials / Clinical Trials ¥°.About Clinical Trial. 1. Definition of clinical trials Although there are many definitions of clinical trials, they are generally considered to be biomedical or health-related research studies in human beings that follow a pre-defined protocol. Observational studies are those in which individuals are observed and their ¡¦
·¹Æ÷Æ® > ±âŸ   6page   1,000 ¿ø
A£« ¿©¼º°Ç°­°£È£ÇÐ Á¤»óÁúºÐ¸¸ NSVD Clinical Pathway ÀÓ»óÁøÇà°úÁ¤

A£« ¿©¼º°Ç°­°£È£ÇÐ Á¤»óÁúºÐ¸¸ NSVD Clinical Pathway ÀÓ»óÁøÇà°úÁ¤

1. ÀÏ¹Ý Á¤º¸ Á¤»ó ÁúºÐ¸¸(NSVD, Normal Spontaneous Vaginal Delivery)Àº Àüü ºÐ¸¸ÀÇ ¾à 70~80%¸¦ Â÷Áö.. / 1. ÀÏ¹Ý Á¤º¸ 2. »ê¸ð·Â 3. ÇöÀç »ê°ú·Â 4. ½Å»ý¾Æ Á¤º¸ 5. ±âŸ 6. ºÐ¸¸Àå °£È£±â·ÏÁö 7. Clinical pathway 8. »ê¸ð¿¡°Ô Åõ¿©µÈ ¾à / 1. ÀÏ¹Ý Á¤º¸ Á¤»ó ÁúºÐ¸¸(NSVD, Normal Spontaneous Vaginal Delivery)Àº Àüü ºÐ¸¸ÀÇ ¾à 70~80%¸¦ Â÷ÁöÇÏ´Â ÈçÇÑ ºÐ¸¸ ¹æ¹ýÀ¸¡¦
¹æ¼ÛÅë½Å > °£È£Çаú   7page   3,000 ¿ø
A£«Clinical Performance Examination

A£«Clinical Performance Examination

1. Station A+Clinical Performance ExaminationÀÇ ` Station`¿¡ ´ëÇÑ ³»¿ëÀº Áß¿äÇÏ´Ù. Station.. / 1. Station 2. Guideline for Observer 3. ½Ã³ª¸®¿À / 1. Station A+Clinical Performance ExaminationÀÇ ` Station`¿¡ ´ëÇÑ ³»¿ëÀº Áß¿äÇÏ´Ù. StationÀº ÀÇÇÐ ±³À°¿¡¼­ ÇлýµéÀÌ Æ¯Á¤ ÀÓ»ó ±â¼úÀ̳ª »óȲÀ» Æò°¡¹Þ´Â Æ÷ÀÎÆ®¸¦ ÀǹÌÇÑ´Ù. º¸Åë ¿©·¯ °³ÀÇ ½ºÅ×À̼ÇÀÌ ¼³Á¤µÇ¾î ÀÖ¡¦
¹æ¼ÛÅë½Å > ±âŸ   3page   3,000 ¿ø
Inhalation sedation½ÃÀÇ Clinical consideration.

Inhalation sedation½ÃÀÇ Clinical consideration.

1. ÈíÀÔÁ¤½Å ¾ÈÁ¤¹ý 2. Contraindicaton. FileSize : 29K / 1. ÈíÀÔÁ¤½Å ¾ÈÁ¤¹ý 2. Contraindicaton. / ÈíÀÔ Á¤½Å ¾ÈÁ¤¹ýÀº ¾àÁ¦ÀÇ Åõ¿© ¹æ¹ýÀÌ ¾ÆÁÖ Æí¸®ÇÑ ¹æ¹ýÀ¸·Î ÀÌ ÈíÀÔ °æ·Î·Î Åõ¿©µÇ´Â ¾àÁ¦´Â ¹ßÇö ½Ã°£, ȸº¹ ½Ã°£ÀÌ ¾ÆÁÖ ½Å¼ÓÇÏ´Ù. À̵éÀº È¿°ú´Â ½Å¼ÓÈ÷ °¡¿ªÈ­µÉ ¼ö ÀÖ´Ù, Åõ¿© ¾àÁ¦ÀÇ ³óµµ¸¦ ³·Ã߰ųª ²÷°í ½Ç³» °ø±â³ª »ê¼Ò¸¦ Åõ¿©ÇÔÀ¸·Î½á ¾àÈ¿´Â ½Å¼ÓÈ÷ °í°¥µÈ´Ù¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   5page   1,000 ¿ø
[Ư¼ö±³À°] ÇнÀÀå¾Ö¿¡ °üÇÑ µÎ°¡Áö ÀÓ»ó »ç·Ê(Clinical Addendum)

[Ư¼ö±³À°] ÇнÀÀå¾Ö¿¡ °üÇÑ µÎ°¡Áö ÀÓ»ó »ç·Ê(Clinical Addendum)

»ç·Ê I: Á³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö(Left-Hemisphere Dysfunction) »ç·Ê II: ¿ì³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö (Right-Hemisphere Dysfunction) FileSize : 35K / »ç·Ê I: Á³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö(Left-Hemisphere Dysfunction) »ç·Ê II: ¿ì³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö (Right-Hemisphere Dysfunction) / Ãâ»ýºÎÅÍ µÎ³úÀÇ ÇÑ ÂÊ Ãø¸é¿¡ ÀÌ»óÀÌ ÀÖ¾ú´ø µÎ »ç·Ê¸¦ ÅëÇؼ­ ½Å°æ½É¸®ÀûÀÎ »óÅ°¡ Á¤½ÅÀû¡¦
·¹Æ÷Æ® > »ç¹ü±³À°   4page   1,400 ¿ø
Clinical Application of Bioactive Glass Granules of Narrow Size Range on Dental Osseous Lesions

Clinical Application of Bioactive Glass Granules of Narrow Size Range on Dental Osseous Lesions

ClinicalApplicationofBioactiveGlassGranules[1]... / ABSTRACT INTRODUCTION Results & Discussion / Results & Discussion Narrow size rangeÀÇ bioactive glass particleÀ» ´Ù·ç´Â °ÍÀº »ðÀÔµµÁß¿¡´Â ½±´Ù. HA particle°ú´Â ¹Ý´ë·Î Ç÷¾×¿¡ Á¢Ã˽à ÀÀÁý¼º ÀÖ´Â µ¢¾î¸®¸¦ Çü¼ºÇϸç Ç÷¾×¿¡ ¶° ´Ù´Ï´Â °æÇâÀ» º¸ÀÌÁö ¾Ê´Â´Ù. Áï °á¼ÕºÎÀ§¿¡ ½±°Ô ¸Å½ÄµÇ¾îÁø´Ù. ÇÑ ¹ø ¸Å½ÄµÈ particleÀº¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   3page   1,000 ¿ø
ÀÓ»ó½É¸® (Clinical psychology)

ÀÓ»ó½É¸® (Clinical psychology)

ÀÓ»ó½É¸®¿Í °ü·ÃµÈ ·ÎÀú½ºÀÇ ÀϺ»ÁÖÀÇ ÀÚ±âÀ̷аú ÇнÀ ¹× ÇൿÀ̷п¡ ´ëÇؼ­ Á¶»çÇÏ¿´½À´Ï´Ù. ÀÓ»ó½É¸® / I. Á¤»ó°ú ºñÁ¤»ó II. Â÷¿ø (dimension) Áúȯ.Áõ»ó III. Roger`sÀκ»ÁÖÀÇÀÇ ÀÚ±â ÀÌ·Ð IV ÇнÀ ¹× ÇൿÀÌ·Ð / I. Á¤»ó°ú ºñÁ¤»ó 1. ¹ý·üÀû Á¤ÀÇ insame ¨çÀ§ÇèÇÏ´Ù ¨è¹«´É·ÂÇÏ´Ù 2. ¹®È­Àû Á¤ÀÇ(Ç¥ÁرâÁØ-°¢³ª¶ó) 3. Åë°èÀû Á¤ÀÇ 4. ÁÖ°üÀû ÆÇ´Ü (personal) 5. Á¾ÇÕÀû, Àü¹®¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   11page   1,000 ¿ø
Clinical microbiology

Clinical microbiology

º» ÀÚ·á´Â Clinical microbiology¿¡ ´ëÇØ Á¤¸®ÇÏ¿´½À´Ï´Ù. Clinicalmicrobiology / -¹Ì»ý¹° ÀÚµ¿È­±â±â ¹× °¢Á¾ µ¿Á¤ KIT 1) ÀüÀÚµ¿ Ç÷¾×¹è¾çÀåÄ¡ 2) Ç×»ó¼º±Õ ÀÚµ¿È­ ¹è¾ç±â 3) ¹Ì»ý¹° ÀÚµ¿È­ °Ë»çÀåÄ¡ 4) µ¿Á¤ kitÀÇ »ç¿ë¹ý°ú ÁÖÀÇÁ¡ -À¯ÀüÀÚ¸¦ ÀÌ¿ëÇÏ´Â °Ë»ç¹ý 1. À¯ÀüÀÚ°Ë»çÀÇ ¸ñÀû 2. À¯ÀüÀÚ°Ë»çÀÇ ¹æ¹ý / ¡ß¹Ì»ý¹° ÀÚµ¿È­±â±â ¹× °¢Á¾ µ¿Á¤ KIT¡ß 1) ÀüÀÚµ¿ Ç÷¾×¹è¾çÀåÄ¡ ÀÓ»ó°Ë¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   6page   1,000 ¿ø
ÇнÀÀå¾Ö¿¡ °üÇÑ µÎ°¡Áö ÀÓ»ó »ç·Ê(Clinical Addendum)

ÇнÀÀå¾Ö¿¡ °üÇÑ µÎ°¡Áö ÀÓ»ó »ç·Ê(Clinical Addendum)

ÇнÀÀå¾Ö¿¡ °üÇÑ µÎ°¡Áö ÀÓ»ó »ç·Ê¸¦ ¼Ò°³ÇÔ ÇнÀÀå¾Ö¿¡°üÇѵΰ¡ÁöÀÓ»ó»ç·Ê / »ç·Ê I: Á³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö(Left-Hemisphere Dysfunction) »ç·Ê II: ¿ì³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö (Right-Hemisphere Dysfunction) / »ç·Ê I: Á³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö(Left-Hemisphere Dysfunction) SamÀº Çб³¿¡¼­ÀÇ Çо÷Àû ¼öÇà·ÂÀÌ ÀúÁ¶ÇÏ°í °£Áú ¹ßÀÛº´·ÂÀ¸·Î ÀÎÇØ 12¼¼ ¶§ ½É°æ½É¸®ÇÐÀû °Ë»ç¸¦ ÀÇ·ÚÇÏ¿´¡¦
·¹Æ÷Æ® > ±âŸ   4page   1,000 ¿ø




ȸ»ç¼Ò°³ | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 ¤Ó ±¤ÁÖ±¤¿ª½Ã ±¤»ê±¸ ¹«Áø´ë·Î 326-6, 201È£ | äÈñÁØ | Åë½Å : ±¤»ê0561È£
Copyright¨Ï ¿Ã·¹¼ÒÇÁÆ® All rights reserved | Tel.070-8744-9518
ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ ¤Ó °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 | Tel.070-8744-9518